A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IgH / Ig heavy chain gene

[Related PubMed/MEDLINE]
Total Number of Papers: 12
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IgH  (>> Co-occurring Abbreviation)
Long Form:   Ig heavy chain gene
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Aryl hydrocarbon receptor-induced activation of the human IGH hs1.2 enhancer: Mutational analysis of putative regulatory binding motifs. AhR, TCDD
2012 AID-targeting and hypermutation of non-immunoglobulin genes does not correlate with proximity to immunoglobulin genes in germinal center B cells. 3D-FISH, AID, Ig
2011 Application of microfluidic technology to the BIOMED-2 protocol for detection of B-cell clonality. FR
2006 Limitations and practical procedure in BclII-Ig heavy chain gene rearrangement real-time quantitative polymerase chain reaction. RQ-PCR
2005 Incomplete DJH rearrangements. MM, MRD, PCR
2004 Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma. Ig
2003 Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications. MM
2000 Characteristics of human IgA and IgM genes used by plasma cells in the salivary gland resemble those used in duodenum but not those used in the spleen. ---
1999 Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32). DLCL, FISH, Ig, LPL, NHL
10  1997 Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease. BM, BMT, MCL, MRD, PCR
11  1996 Rearrangement of the 5' cluster region of the BCL2 gene in lymphoid neoplasm: a summary of nine cases. CLL, Ig, MBR, mcr, NHL
12  1992 Changing antigen receptor gene rearrangements in a case of early pre-B cell leukemia: evidence for a tumor progenitor cell with stem cell features and implications for monitoring residual disease. ALL, BM, N-PCR